Rotavirus specific antibodies in fetal bovine serum and commercial preparations of serum albumin

(1)Vol. 20, No. 2. JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1984, p. 266-270 0095-1137/84/080266-05$02.00/0 Copyright © 1984, American Society for Microbiology. Rotavirus-Specific Antibodies in Fetal Bovine Serum and Commercial Preparations of Serum Albumin PAUL A. OFFIT,l2* H. FRED CLARK,1'2 ALEX H. TAYLOR,' R. GUENTER HESS,3 PETER A. BACHMANN,3 AND STANLEY A. PLOTKIN1,2 The Wistar Institute of Anatomy and Biology' and Division of lnfectious Diseases, The Children's Hospital of Philadelphia,2 Philadelphia, Pennsylvania 19104, and Infectious and Epidemic Diseases, Veterinary Faculty, Institute for Medical Microbiology, University of Munich, 8000 Munich 22, Federal Republic of Germany3 Received 29 March 1984/Accepted 14 May 1984. [wt/vol]) were prepared in phosphate-buffered saline (PBS) for use in these studies. HSA was obtained from Cutter Laboratories (Berkeley, Calif.; Plasbumin-25, stock no. 68420). Blood samples were obtained under our supervision (Institute for Medical Microbiology, Munich, Federal Republic of Germany) from the external jugular vein of cesarian-derived Holstein-Friesian or Fleckvieh calves before colostral feeding. All serum preparations were treated at 56°C for 30 min. Serum preparations adsorbed with Staphylococcus aureus Cowan 1 were reacted with 10 mg of the bacterium per ml of serum. After incubation at 0°C for 1 h, bacteria were removed by centrifugation for 2 min at 12,800 x g. Supernatant portions were used for further testing. RIP of rotavirus proteins. Purified double-shelled NCDV virions were labeled with 1251 by the chloramine-T method (10). 125I-labeled virus preparations (60,000 trichloroacetic acid-precipitable cpm/pI) were adsorbed with S. aureus Cowan 1 by adding 500 RlI of 10% S. aureus Cowan 1 to 1.0 ml of labeled virus. After incubation for 15 min at 0°C, the bacteria were removed by centrifugation for 2 min at 12,800. The prevalence of rotavirus-specific antibodies in the sera of domestic and laboratory animals is extensive (27, 32). Investigators performing serological studies of rotaviruses must therefore pay scrupulous attention to avoiding the use of adult animal sera containing rotavirus antibodies. It has generally been assumed that the risk of encountering naturally occurring antibodies in serological reagents can be avoided by the use of fetal bovine serum (FBS), bovine serum albumin (BSA), or human serum albumin (HSA). However, the finding of neutralizing activity in commercial FBS (9) led us to further investigate FBS as well as BSA and HSA for the presence of rotavirus antibodies. We have found rotavirus-specific antibodies by radioimmunoprecipitation (RIP) in commercial preparations of FBS, BSA, and HSA as well as in serum samples obtained under our supervision from precolostral calves. The incidence of such antibodies in these reagents and their identification as immunoglobulins with specific antirotavirus activity are described in this report.. MATERIALS AND METHODS Cells and viruses. Fetal rhesus monkey kidney cells (MA104) were grown in BHK cell medium (22) supplemented with 10% FBS, 100 U of penicillin per ml, and 100 ,ug of streptomycin per ml. The bovine rotavirus strain NCDV, adapted to growth in tissue culture at the Norden Laboratories (Lincoln, Nebr.), was generously provided by Robert Yolken (Baltimore, Md.). The Wa strain of human rotavirus was obtained from Richard Wyatt (Bethesda, Md.). Viral growth, purification, and quantitation were performed as previously described (26). Serum preparations. Commercial lots of FBS were purchased from Flow Laboratories, Inc. (McLean, Va.) MA Bioproducts (Walkersville, Md.), Biocell (Carson, Calif.), GIBCO L-aboratories (Grand Island, N.Y.), and Boehringer Mannheim Biochemicals (Indianapolis, Ind.). Crystalline bovine albumin was purchased from Sigma Chemical Co. (St. Louis, Mo.; stock no. A 7030) and Calbiochem-Behring (La Jolla, Calif.; stock no. 12657). Albumin solutions (25% *. x g. The adsorbed supernatant fluids were then divided into to which 50 ,ul of the serum preparation was added. After incubation for 18 h at 4°C, 80 ,ul of 10% S. aureus Cowan 1 was added to each serum-virus mixture and held at 0°C for 1 h. The bacteria were then pelleted and. 5-Rl portions. washed four times with PBS containing 0.1% sodium dodecyl sulfate (SDS) and 0.5% Triton X-100. The adsorbed, labeled proteins were recovered by suspending the bacterial pellets in 20 ,ul of sample buffer containing 0.25 M Trishydrochloride (pH 6.8), 20% glycerol, 1% SDS, 2% 2mercaptoethanol, and 0.003% phenol red and boiling the suspension for 2 min. The bacteria were pelleted, and the supernatant fluids were applied to SDS-polyacrylamide gels. Discontinuous SDS-PAGE. Discontinuous SDS-polyacrylamide gel electrophoresis (PAGE) was performed by using a 10% acrylamide separating gel as previously described (19). In experiments designed to determine the molecular weight of nonreduced purified bovine immunoglobulin, 2-mercaptoethanol was omitted from the sample buffer. Electrophoresis was performed at 30 mA per gel. Molecular weight standards (Bio-Rad Laboratories, Richmond, Calif.) were detected by staining with silver nitrate as described. Corresponding author.. 266. Downloaded from http://jcm.asm.org/ on February 8, 2020 by guest. Rotavirus-specific antibodies were detected in fetal bovine serum, bovine serum albumin, and human serum albumin by radioimmunoprecipitation with the NCDV strain of bovine rotavirus as the detecting antigen. Fetal bovine sera neutralized bovine rotavirus in a plaque reduction neutralization test to titers of 1:20 or greater. Immunoglobulins purified from fetal bovine serum by protein A-agarose affinity chromatography precipitated rotavirus antigens but did not neutralize bovine rotavirus. Rotavirus antibodies in fetal bovine serum and in purified serum albumin preparations may interfere with diagnostic assays for the detection of rotavirus antigens or antibodies..

(2) ROTAVIRUS ANTIBODIES IN FBS. VOL. 20, 1984 1 2 3 4 5 6 7 8 9 101112131415161718. 116,. 94-. 88 :. P-. la*.,. I* -- I*.,*. *1 1. ~. 84. 61. - is w. 61. 4 1-. -. 0 *-_b Om*. M. FIG. 1. 125I-labeled, purified, double-shelled NCDV virions separated by electrophoresis in 10% SDS-polyacrylamide gels and visualized by fluorography (lane 1). Numbers refer to the molecular weights (in thousands) of the viral polypeptides. RIP analysis of 100, 10, and 5% FBS from Flow (lanes 2 to 4), Biocell (lanes 5 to 7), and MA Bioproducts (lanes 8 to 10), 25 and 2.5% BSA from Sigma (lanes 11 and 12) and Calbiochem-Behring (lanes 13 and 14), 25, 2.5, and 1.25% HSA from Cutter Laboratories (lanes 15 to 17), and PBS control (lane 18) with the NCDV strain of bovine rotavirus as the detecting antigen. were. by Merril et al. (25). Fluorograms were prepared as described by Laskey and Mills (20). PRN assay. The plaque reduction neutralization (PRN) assay was a modification of the technique described previously by Matsuno et al. (23). A virus suspension containing 500 PFU of bovine rotavirus (NCDV) per ml was mixed with an equal volume of serial fivefold dilutions of serum preparations. The serum-virus mixture was incubated in a water bath at 37°C for 30 min. Confluent monolayers of MA-104 cells in 6-well plates were washed twice with PBS. The serum-virus mixture (0.2 ml) was then inoculated onto MA104 cells and incubated for 30 min at 37°C. The plates were again washed twice with PBS, and 2.5 ml of overlay medium consisting of 0.5% purified agar (agarose; Seakem) and 13 Fg of trypsin (Flow) per ml in Eagle minimal essential medium was added. The cultures were placed in a humidified incubator for 4 days at 37°C in 5% CO2. A second overlay medium containing 0.5% purified agar and 0.03% neutral red in Earle balanced salt solution was then added, and the plaques were counted ca. 5 h later. A greater than 50% reduction in viral plaques was considered to be a positive result at a given serum dilution. Protein A-agarose affinity chromatography. Affinity chromatography was carried out on columns (2 by 11 cm) of protein A-agarose (Boehringer Mannheim). FBS (MA Bioproducts) was passed through the column at a flow rate of 25 ml/h at 25°C. The column was then washed with BrittonRobinson (5) buffer (pH 7.0), and when the absorbance of the effluent at 280 nm was zero, the adsorbed proteins were eluted with a linear pH gradient from 7.0 to 3.0. All fractions with an absorbance greater than 0.002 were pooled, and the pH was adjusted to 7.0 by the addition of 0.5 M Na2HPO4 solution (pH 7.4). The pooled fractions were then concentrated 30-fold through a collodion bag (Schleicher & Schuell. Inc., Keene, N.H.) with an exclusion molecular weight of 75,000. To estimate the concentration of eluted immunoglobulins, it was assumed that 1.4 absorbance units at 280 nm represented a concentration of 1.0 mglml (33). RESULTS 125I-labeling of structural rotavirus polypeptides by RIP. Figure 1 (lane 1) shows the SDS-PAGE pattern of iodinated rotavirus structural polypeptides. Proteins with molecular weights of 116,000, 94,000, 88,000, 84,000, 41,000, and 37,000 were identified. These proteins are components of the inner and outer capsid of bovine rotavirus (26). The 37kilodalton protein is the major outer capsid glycoprotein associated with viral neutralization (11). Analysis of commercial serum preparations by RIP. Commercial preparations of FBS, BSA, and HSA were found by RIP to contain antibodies directed against rotavirus structural proteins with molecular weights of 116,000, 94,000, 88,000, 84,000, and 41,000 (Fig. 1). Rotavirus atitibodies were detected in 5% FBS, 2.5% BSA, and 1.25% HSA solutions (Fig. 1). Twelve additional lots of FBS were found to contain rotavirus-specific antibodies at similar concentrations (data not shown). Identification of immunoglobulins as source of RIP activity. (i) Protein A-agarose affinity chromatography of FBS. FBS (50 ml) found previously to have rotavirus-specific antibodies by RIP (Fig. 1, lanes 8 to 10) was passed through a protein A-agarose column, followed by a linear pH gradient elution. Fractions with an absorbance greater than 0.002 were eluted between pH 6.15 and 5.41, with the peak absorbance fraction eluted at pH 5.8. Eight micrograms of eluted immunoglobulins per ml of FBS were recovered from pooled and concentrated fractions. (ii) Discontinuous SDS-PAGE of protein A-purified immunoglobulins. The results of SDS-PAGE of purified immunoglobulins treated with reducing or nonreducing sample buffer and stained with silver nitrate are illustrated in Fig. 2. Unreduced immunoglobulins were demonstrated by a single band with a molecular weight of 150,000, and reduced immunoglobulins were cleaved into heavy and light chains. 1. 2. 150 -. 50-. -. 28FIG. 2. SDS-PAGE of immunoglobulins purified from FBS treated with reducing (lane 1) or nonreducing (lane 2) sample buffer and stained with silver nitrate. Numbers refer to the molecular weights (in thousands) of visualized proteins.. Downloaded from http://jcm.asm.org/ on February 8, 2020 by guest. I. 267.

(3) 268. J. CLIN. MICROBlOL.. OFFIT ET AL.. DISCUSSION We have found that antibodies directed against rotavirus proteins are consistently present in FBS. Sato et al. (28) detected hemagglutination-inhibiting antibodies to bovine rotavirus in the sera of 27 of 29 precolostral calves at dilutions of 1:2 to 1:128. Using a complement-fixation assay, Estes et al. (9) were unable to detect rotavirus antibodies in commercial preparations of FBS. However, they found that inclusion of FBS into viral growth medium decreased rotavirus infectivity 5- to 15-fold. Our studies with S. aureus Cowan 1-adsorbed FBS and immunoglobulins purified from FBS clearly show that antirotavirus activity detected by RIP is due to immunoglobulins. The antibodies detected in our studies of FBS, BSA, and HSA may interfere with standard assays for antibody or antigen detection (e.g., radioimmunoassay, enzyme-linked immunosorbent assay) or with assays which evaluate the viral structural specificities of. 1 234567. 116 - a 94 88 7 0 84 6141. 4. ,_. 37'._. FIG. 3. "25I-labeled, purified, double-shelled NCDV virions separated by electrophoresis in 10% SDS-polyacrylamide gels and visualized by fluorography (lane 1). Numbers refer to the molecular weights (in thousands) of viral polypeptides. RIP analysis of 100, 10 and 5% neonatal (lanes 2 to 4) and 0.2, 0.02, and 0.002% maternal (lanes 5 to 7) bovine serum obtained during cesarian delivery with the NCDV strain of bovine rotavirus as the detecting antigen.. polyclonal or monoclonal antibody preparations (e.g., RIP, Western blot analysis). Purified immunoglobulins recovered from FBS by protein A affinity chromatography did not appear to be responsible for the observed neutralization of rotaviruses by FBS. This finding is consistent with the fact that these immunoglobulins are not directed against the 37-kilodalton major outer capsid glycoprotein associated with viral neutralization (11). Antibodies directed against inner capsid and outer capsid proteins were detected in maternal serum at serum dilutions of 1:50,000 and 1:500, respectively. The concentration of rotavirus-specific antibodies in FBS was ca. 2,500-fold less than that detected in maternal serum; our inability to detect antibodies directed against the 37-kilodalton outer capsid protein in neonatal sera most likely reflects these concentration differences. Rotavirus neutralization associated with FBS may be the result of either serum antiprotease activity (9) or of bovine immunoglobulins which do not bind to protein A. To our knowledge, there are no published reports documenting the presence of rotavirus-specific antibodies in commercial albumin preparations. The detection of these antibodies may be explained by (i) the extensive prevalence of rotavirus antibodies in random and convalescent sera obtained from both animals and humans (7, 23, 27, 32) and (ii) the indication (suppliers catalog) that these albumin preparations may contain trace amounts of globulin. The detection of antibodies in HSA directed against bovine rotavirus proteins is consistent with previous reports of shared antigenic determinants on both the inner and outer capsids of rotaviruses of bovine, human, and other mammalian origins (26). Transplacental transfer of immunoglobulins presumably. Downloaded from http://jcm.asm.org/ on February 8, 2020 by guest. demonstrated by bands with molecular weights of 50,000 and 28,000, respectively. (iii) Analysis of purified bovine immunoglobulins by RIP. Purified immunoglobulins at a concentration of 20 ,ug/ml were found to have rotavirus-specific antibodies by RIP directed against proteins with molecular weights of 116,000, 94,000, 88,000, 84,000, and 41,000. Rotavirus-specific antibodies were not detected by RIP of protein A-agaroseadsorbed FBS. Analysis of serum preparations by PRN. Three commercial lots of FBS shown by RIP (Fig. 1, lanes 2 to 4, 5 to 7, 8 to 10) to contain rotavirus-specific antibodies were tested by PRN. All three lots of FBS tested at a concentration of 5% caused a ¢50% plaque reduction of bovine rotavirus strain NCDV. Preparations of 12.5% BSA and 12.5% HSA did not neutralize bovine or human (strain Wa) rotaviruses. Role of bovine immunoglobulins in rotavirus inactivation by FBS. To determine whether rotavirus-specific immunoglobulins were associated with the rotavirus-neutralizing activity of FBS, a 5% solution of three different lots of FBS was adsorbed with S. aureus Cowan 1. The adsorbed solutions were assayed for rotavirus-specific antibodies by RIP and for neutralizing activity by PRN. No rotavirus-specific antibodies were detected in the adsorbed solutions by RIP; however, rotavirus-neutralizing activity was detected at concentrations identical to those found in unadsorbed preparations. Conversely, immunoglobulins purified from FBS did not neutralize NCDV rotavirus at a concentration of 200 p.g/ml. Source of bovine immunoglobulin in FBS. To determine whether the immunoglobulins detected in commercial FBS were the result of either colostral feeding or mixing of maternal with fetal sera, 10 cesarian-derived calves were bled under our supervision before colostral feeding. All 10 sera were found to have rotavirus-specific antibodies by RIP at concentrations similar to those found in commercial lots of FBS (data not shown). Serum specimens from both mother and neonate were obtained during one cesarian delivery. Neonatal and maternal sera (tested at concentrations of 5 and 0.002%) contained antibodies directed against rotavirus proteins with molecular weights of 116,000, 94,000, 88,000, 84,000, and 41,000 (Fig. 3). At a higher concentration of maternal serum (0.2%), antibodies directed against the 37-kilodalton major outer capsid glycoprotein were also demonstrable (Fig. 3). Neonatal and maternal sera neutralized rotavirus strain NCDV by PRN at dilutions of 1:40 and 1:830, respectively..

(4) ROTAVIRUS ANTIBODIES IN FBS. VOL. 20, 1984. ACKNOWLEDGMENTS This work was supported by Public Health Service grant F 32 Al06733 from the National Institutes of Health to P.A.O. and in part by the Hassel Foundation and the Merieux Institute. We thank Walter Gerhard for support of this work. We also thank Charles Hackett, Jan Tuttleman, and Jon Yewdell for helpful discussions and careful reading of the manuscript. LITERATURE CITED 1. Baker, J. A., C. York, J. H. Gillespie, and G. B. Mitchell. 1954. Viral diarrhea in cattle. Am. J. Vet. Res. 15:525-531. 2. Boone, C. W., N. Mantel, T. D. Caruso, E. Kazam, and R. E. Stevenson. 1972. Quality control studies on fetal bovine serum used in tissue culture. In Vitro 7:174-189. 3. Bowne, J. G., A. J. Luedke, M. M. Jochim, and H. E. Metcalf. 1968. Blue-tongue disease in cattle. J. Am. Vet. Med. Assoc. 153:662-668. 4. Brambell, F. W. R. 1970. The transmission of passive immunity from mother to young, vol. 18. In A. Neuberger and E. L. Tatum (ed.), Frontiers of biology. North-Holland Publishing Co.. London. 5. Britton, H. T. S., and G. Welford. 1937. The standardisation of some buffer solutions at elevated temperatures. J. Chem. Soc. 1937:1848-1852. 6. Chow, T. L., J. A. Molello, and N. V. Owen. 1964. Abortion experimentally induced in cattle by infectious bovine rhinotracheitis virus. J. Am. Vet. Med. 144:1005-1007. 7. Elias, M. M. 1977. Distribution and titres of rotavirus antibodies in different age groups. J. Hyg. 79:365-372. 8. Ellis, W. A., E. F. Logan, and J. J. O'Brien. 1978. Serum immunoglobulins in aborted and non-aborted bovine fetuses.. Clin. Exp. Immunol. 33:136-141. 9. Estes, M. K., D. Y. Graham, C. P. Gerba, and E. M. Smith. 1979. Simian rotavirus SAl1 replication in cell cultures. J. Virol. 31:810-815. 10. Glazer, A. N. 1976. The chemical modification of proteins by group-specific and site-specific reagents, p. 2-103. In H. Nesrath, R. 1. Hill, and C. L. Boeder (ed.), The proteins. vol. 2. Academic Press, Inc., New York. 11. Greenberg, H. B., J. Valdesuso, K. van Wyke, K. Midthun, M. Walsh, V. McAuliffe, R. G. Wyatt, A. R. Kalica, J. Flores, and Y. Hoshino. 1983. Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J. Virol. 47:267-275. 12. Husband, A. J., M. R. Brandon, and A. K. Lascelles. 1972. Absorption and endogenous production of immunoglobulins in calves. Aust. J. Exp. Biol. Med. Sci. 50:491-498. 13. Ivanoff, M. R., and H. W. Renshaw. 1975. Weak calf syndrome: serum immunoglobulin concentrations in precolostral calves. Am. J. Vet. Res. 36:1129-1131. 14. Jalnapurkar, B. V., S. M. Ajinkya, and P. D. Sardeshpande. 1976. Immunoglobulin G in the serum of newborn buffalo (bos bulbalus bubalis) calves. Vet. Rec. 99:146. 15. Jensen, R., L. A. Griner, T. L. Chow, and W. W. Brown. 1956. Infectious bovine rhinotracheitis in feedlot cattle. Proc. U.S. Livestock Sanit. Assoc. 59:189-199. 16. Kendrick, J. W. 1971. Bovine viral diarrhea-mucosal disease viral infection in pregnant cows. Am. J. Vet. Res. 32:533-544. 17. Kirkbridge, C. A., D. Martinovich, and P. A. Woodhouse. 1972. Immunoglobulins and lesions in aborted bovine foetuses. N.Z. Vet. J. 25:180-187. 18. Klaus, G. G. B., A. Bennett, and E. W. Jones. 1969. A quantitative study of the transfer of colostral immunoglobulins to the newborn calf. lmmunology 16:293-299. 19. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685. 20. Laskey, R. A., and A. D. Mills. 1975. Quantitative film detection of -H and 14C in polyacrylamide gels by fluorography. Eur. J. Biochem. 56:335-341. 21. Luedke, A. J., M. M. Jochim, J. G. Bowne, and R. H. Jones. 1970. Observations on latent bluetongue virus in cattle. J. Am. Vet. Med. Assoc. 156:1871-1879. 22. MacPherson, I., and M. Stoker. 1962. Polyoma transformation of hamster cell clones-an investigation of genetic factors affecting cell competence. Virology 16:147-151. 23. Matsuno, S., S. Inouye, and R. Kono. 1977. Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera. J. Clin. Microbiol. 5:1-4. 24. McKercher, D. G., J. K. Saito, and K. V. Singh. 1970. Serologic evidence of an etiologic role of bluetongue virus in hydranencephaly of calves. J. Am. Vet. Med. Assoc. 156:1044-1047. 25. Merril, C. R., D. Goldman, S. A. Sedman, and M. H. Ebert. 1980. Ultrasensitive strain for proteins in polyacrylamide gels shows regional variation of cerebrospinal fluid proteins. Science 211:1437-1438. 26. Offit, P. A., H. F. Clark, and S. A. Plotkin. 1983. Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization. Infect. Immun. 42:293-300. 27. Sato, K., Y. Inaba, T. Shinozaki, and M. Matumoto. 1981. Neutralizing antibody to bovine rotavirus in various animal species. Vet. Microbiol. 6:259-261. 28. Sato, K., Y. Inaba, S. Tokuisa, Y. Miura, H. Akashi, and Y. Tanaka. 1980. Antibodies against several viruses in sera from normal bovine fetuses and precolostral calves. Natl. Inst. Anim. Health Q. 20:77-78. 29. Sawyer, M., B. I. Osburn, H. D. Knight, and J. W. Kendrick. 1973. A quantitative serologic assay for diagnosing congenital infections of cattle. Am. J. Vet. Res. 34:1281-1284. 30. Schultz, R. D., H. W. Dunne, and C. E. Heist. 1973. Ontogeny of the bovine immune response. Infect. Immun. 7:981-991. 31. Solomon, J. B. 1971. Foetal and neonatal immunology, vol. 20. In A. Neuberger and E. L. Tatum (ed.), Frontiers of biology.. Downloaded from http://jcm.asm.org/ on February 8, 2020 by guest. does not occur in cattle (4). This fact is difficult to reconcile with our consistent finding of antirotavirus immunoglobulins in FBS. Several investigators have detected immunoglobulin G in FBS by radial immunodiffusion at concentrations of 13 to 859 ,ug/ml; maternal immunoglobulin G was detected in maternal serum at a concentration of ca. 50 mg/ml (2, 8, 1214, 17, 18, 29). We have detected rotavirus-specific antibodies in maternal serum at concentrations 2,500- and 20-fold greater than precolostral calf serum by RIP and PRN, respectively. Our results are consistent with the immunoglobulin concentration differences detected between fetal and maternal sera by radial immunodiffusion. The finding of rotavirus-specific antibodies in 10 sera collected under our supervision from precolostral calves excludes the possibilities that antibodies in commercial sera were the result of either (i) mixing of maternal with fetal sera during or after collection or (ii) collection of sera after colostral feeding. The bovine fetus is able to respond to certain antigenic stimuli beginning at ca. day 118 of gestation (31). Bovine viral diarrhea, infectious bovine rhinotracheitis, and bluetongue viruses have been found to cross the placental barrier and to induce a specific immune response by the fetus (1, 3, 6, 14-16, 21, 24, 30). Wyatt et al. (34) demonstrated that the bovine fetus can generate a vigorous immune response in utero to bovine rotavirus; when seven calves were inoculated with the bovine rotavirus NCDV 2 to 14 weeks before delivery, neutralizing antibodies were detected in cord serum at dilutions of 1:370 to 1:17,975. However, viremia and fetal disease have never been documented in rotavirus infections. Since rotaviruses are not known to cause in utero infection, our consistent detection of rotavirus-specific antibodies in 5% FBS by RIP suggests that immunoglobulins are passively transferred across an intact bovine placenta in small but detectable quantities before partuition.. 269.

(5) 270. OFFIT ET AL.. Elsevier/North-Holland Publishing Co., New York. 32. Thouless, M. E., A. S. Bryden, T. H. Flewett, and G. N. Woode. 1977. Serological relationships between rotaviruses from different species as studied by complement-fixation and neutralization. Arch. Virol. 53:287-294. 33. Williams, C. A., and M. W. Chase (ed.). 1968. Methods in. J. CLIN. MICROBIOL.. immunology and immunochemistry, vol. 2, p. 344. Academic Press, Inc., New York. 34. Wyatt, R. G., A. Z. Kapikian, and C. A. Mebus. 1983. Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus. J. Clin. Microbiol. 18:505-508.. Downloaded from http://jcm.asm.org/ on February 8, 2020 by guest.

(6)

New documents

This is only a small sample of the published work in leisure studies and leisure theory, of course, but I suggest that the morally grounded nature of the leisure in leisure studies

Purpose: To evaluate the impact of pre-procedural coronary plaque composition assessed by virtual histology intravascular ultrasound VH-IVUS on late stent malapposition assessed by

When re-reading The Future of Work and Leisure one feels a sense of confidence and optimism in the ability of rational people to plan and act to make the world a better place for all of

AF and HRV HRV relies on the principle that the pattern of beat-to-beat control of the sinoatrial node provides a reflection of cardiac autonomic nerve activity.14 Among multiple

‘It's a part of me’: An ethnographic exploration becoming a disabled sporting cyborg following spinal cord injury Abstract In much research dealing with sport technologies and the

An interim analysis showed that the intracoronary injection of fhADCs was feasible and safe, and showed a trend toward improved cardiac function and perfusion defects, and reduced

Discussion That low-level, preventative support is needed for adults with high functioning autism spectrum disorder HFASD at risk of experiencing poor physical and mental health,

The relationships between Community Foundations and the statutory health sector There are numerous statutory health organisations that Community Foundations might work with, including

The major findings on electrical abnormalities were as follows; 1 more than half of patients had a repolarization abnormality presenting LV strain and QT prolongation, 2 giant negative

I examine my own experience as a doctoral student setting off to conduct a piece of participatory research to explore the potential for Association Football football fandom to be a